Two NFATc2-related axes control cancer progression: the NEDD4/FBP1 axis in cholangiocarcinoma [29] and the MYC/NFATc2 axis in acute myeloid leukemia (AML) cells [30]. Here, NEDD4 is linked to cholangiocarcinoma.